EC
OLMA icon

EntryPoint Capital’s Olema Pharmaceuticals OLMA Stock Holding History

EntryPoint Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
+14,454
New +$194K 0.04% 705
2025
Q1 		– Sell
-69,526
Closed -$405K – 877
2024
Q4 		$405K Buy
69,526
+34,982
+101% +$349K 0.17% 198
2024
Q3 		$412K Sell
34,544
-5,183
-13% -$66.3K 0.23% 112
2024
Q2 		$430K Buy
39,727
+25,197
+173% +$273K 0.2% 64
2024
Q1 		$164K Buy
14,530
+13,146
+950% +$170K 0.15% 179
2023
Q4 		$19.4K Buy
+1,384
New +$18.6K 0.02% 1055

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

EntryPoint Capital's OLMA Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 14,454 shares worth $181K. The stake represents 0.04% of the portfolio and ranks #705 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in OLMA as recently as Q4 2024.

EntryPoint Capital first reported a position in OLMA in Q4 2023 and has held it in 6 quarters since. The position peaked at $430K in Q2 2024. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • EntryPoint Capital held 14,454 shares of Olema Pharmaceuticals worth $181K as of Q2 2026.
  • Olema Pharmaceuticals was a new EntryPoint Capital position in Q2 2026.
  • Olema Pharmaceuticals made up 0.04% of EntryPoint Capital's portfolio in Q2 2026, its #705 holding.
  • EntryPoint Capital first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • EntryPoint Capital's Olema Pharmaceuticals position peaked at $430K in Q2 2024.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.